{"id":"https://openalex.org/W2533000830","doi":"https://doi.org/10.1182/blood.v126.23.982.982","title":"Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia","display_name":"Pharmacokinetics-Based Individualized Dosing Strategy to Predict Maximum Tolerated Dose of Hydroxyurea in Children with Sickle Cell Anemia","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2533000830","doi":"https://doi.org/10.1182/blood.v126.23.982.982","mag":"2533000830"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.982.982","doi":"https://doi.org/10.1182/blood.v126.23.982.982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.982.982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017286562","display_name":"Patrick T. McGann","orcid":"https://orcid.org/0000-0001-6198-4785","observed_orcids":["https://orcid.org/0000-0001-6198-4785"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick T. McGann","raw_affiliation_strings":["Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090500677","display_name":"Min Dong","orcid":"https://orcid.org/0000-0002-8552-8298","observed_orcids":["https://orcid.org/0000-0002-8552-8298"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Min Dong","raw_affiliation_strings":["Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040752648","display_name":"Russell E. Ware","orcid":"https://orcid.org/0000-0001-9582-0594","observed_orcids":["https://orcid.org/0000-0001-9582-0594"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Russell E. Ware","raw_affiliation_strings":["Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040060343","display_name":"Alexander A. T. M. M. Vinks","orcid":"https://orcid.org/0000-0003-4224-2967","observed_orcids":["https://orcid.org/0000-0003-4224-2967"]},"institutions":[{"id":"https://openalex.org/I1285204247","display_name":"Cincinnati Children's Hospital Medical Center","ror":"https://ror.org/01hcyya48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285204247"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alexander A Vinks","raw_affiliation_strings":["Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH","institution_ids":["https://openalex.org/I1285204247"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040060343","https://openalex.org/A5090500677"],"corresponding_institution_ids":["https://openalex.org/I1285204247"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31274479,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"982","last_page":"982"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6484000086784363,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.6484000086784363,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.32690000534057617,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.005900000222027302,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7609999775886536},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.8130000233650208},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7670000195503235},{"id":"https://openalex.org/keywords/michaelis-menten-elimination","display_name":"Michaelis-Menten elimination","score":0.8949999809265137},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.421999990940094},{"id":"https://openalex.org/keywords/cystatin-c","display_name":"cystatin C","score":0.9940000176429749},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.6290000081062317},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7409999966621399},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.5559999942779541},{"id":"https://openalex.org/keywords/auc","display_name":"AUC","score":0.33399999141693115}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.784325361251831},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7756912708282471},{"id":"https://openalex.org/C2776239304","wikidata":"https://www.wikidata.org/wiki/Q6954915","display_name":"NONMEM","level":3,"score":0.6055350303649902},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5938172340393066},{"id":"https://openalex.org/C2778620579","wikidata":"https://www.wikidata.org/wiki/Q185034","display_name":"Sickle cell anemia","level":3,"score":0.5324726104736328},{"id":"https://openalex.org/C2779316324","wikidata":"https://www.wikidata.org/wiki/Q212272","display_name":"Hydroxycarbamide","level":3,"score":0.4802016019821167},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.46851348876953125},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45147010684013367},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.45095008611679077},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4029678702354431},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3731895983219147},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.36980390548706055},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.982.982","doi":"https://doi.org/10.1182/blood.v126.23.982.982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.982.982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2735618937","https://openalex.org/W2172684893","https://openalex.org/W2533785708","https://openalex.org/W4405043834","https://openalex.org/W4310161270","https://openalex.org/W2944852231","https://openalex.org/W2913874492","https://openalex.org/W2913883561","https://openalex.org/W2742410006","https://openalex.org/W4405043441"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Hydroxyurea":[2,205,289,309,617],"is":[3,484,512,565,618],"the":[4,49,76,101,105,140,155,165,176,203,252,279,346,351,357,422,427,434,517,570,577,583,590,602],"primary":[5,124],"disease-modifying":[6],"therapy":[7,38,587,595],"for":[8,23,28,147,170,181,188,235,350,491,552,596,621],"adults":[9],"and":[10,33,56,78,104,162,229,246,256,267,304,362,401,433,483,488,521,588,604],"children":[11,84,148,198,465,597,622],"with":[12,85,95,149,199,283,300,316,466,598,623],"sickle":[13,624],"cell":[14,625],"anemia":[15],"(SCA).":[16],"Recent":[17],"NHLBI":[18],"guidelines":[19],"include":[20],"a":[21,158,216,272,296,305,419,438,443,454,536],"recommendation":[22],"expanded":[24],"hydroxyurea":[25,37,145,185,269,348,371,386,411,462,497,529,559,594],"use,":[26],"particularly":[27,490],"young":[29,493],"children.":[30],"The":[31,60,123,238,327,562],"laboratory":[32,58,77,603],"clinical":[34,79,230,286,605],"benefits":[35,606],"of":[36,51,126,157,164,178,184,207,258,285,370,385,445,540,555,572,593],"are":[39,531,609],"optimized":[40],"when":[41],"escalated":[42],"to":[43,62,92,118,130,138,143,174,214,261,324,436,460,477,575,585],"maximum":[44],"tolerated":[45],"dose":[46,52,439,539,591],"(MTD),":[47],"but":[48,94,373],"process":[50],"escalation":[53,68],"requires":[54,472,501],"expertise":[55],"frequent":[57,502],"tests.":[59],"time":[61,141],"reach":[63,144],"MTD":[64,89,102,146,331,463,564,608],"using":[65,220,278,426,533],"traditional":[66,496],"empirical":[67],"usually":[69],"takes":[70],">6":[71],"months,":[72],"which":[73],"can":[74],"delay":[75],"benefits.":[80],"In":[81,527],"addition,":[82],"all":[83],"good":[86],"adherence":[87],"at":[88,194,330,396,607],"will":[90],"respond":[91],"hydroxyurea,":[93],"substantial":[96,313],"interpatient":[97,314],"variability":[98,315],"in":[99,113,202,464,516],"both":[100],"itself":[103],"%HbF":[106],"levels":[107],"achieved,":[108],"suggesting":[109],"important":[110],"individual":[111,189,264],"differences":[112],"pharmacokinetics":[114],"(PK)":[115],"that":[116,391,440,500,601],"contribute":[117],"this":[119,127,152,341],"phenotypic":[120],"variability.":[121],"Objective:":[122],"objective":[125,153],"study":[128],"was":[129,241,276,335,343,381],"develop":[131,215],"an":[132,416],"individualized":[133,457],"Bayesian":[134,171,510],"adaptive":[135],"dosing":[136,458],"strategy":[137,459,471,581],"reduce":[139,175],"required":[142,154,180,260,574],"SCA.":[150,467],"Achieving":[151],"development":[156],"population":[159,217],"PK":[160,186,192,218,265,281,290,353,423,455,498,560],"model":[161,219,240,282,299],"identification":[163],"most":[166],"informative":[167],"sampling":[168,254,429,470],"times":[169,255],"estimation":[172,183],"order":[173],"number":[177,257],"observations":[179],"robust":[182],"parameters":[187,266],"patients.":[190],"Methods:":[191],"data":[193],"baseline":[195],"from":[196,322,418],"96":[197],"SCA":[200],"enrolled":[201],"prospective":[204],"Study":[206],"Long-term":[208],"Effects":[209],"(HUSTLE,":[210],"NCT00305175)":[211],"were":[212,233,292,365],"used":[213],"nonlinear":[221],"mixed":[222],"effects":[223],"modeling":[224,435],"(NONMEM":[225],"7.2).":[226],"Patient":[227],"demographics":[228],"chemistry":[231],"measurements":[232],"included":[234],"covariate":[236],"analyses.":[237],"final":[239,280,352],"validated":[242],"by":[243,295],"bootstrap":[244],"analysis":[245,275,499],"visual":[247],"predictive":[248],"check.":[249],"To":[250],"identify":[251],"optimal":[253],"samples":[259,476,548],"robustly":[262],"estimate":[263,409],"total":[268],"exposure":[270],"(AUC),":[271],"D-optimal":[273,388],"design":[274,389],"performed":[277],"constraints":[284],"feasibility.":[287],"Results:":[288],"profiles":[291],"best":[293],"described":[294],"one":[297],"compartment":[298],"Michaelis":[301],"Menten":[302],"elimination":[303],"transit":[306],"absorption":[307],"model.":[308],"serum":[310,375,393,475],"concentrations":[311,394,530],"showed":[312],"AUC":[317,329,349,444],"on":[318,569],"Day":[319],"1":[320,414],"ranging":[321],"40.0":[323],"149.2":[325],"mg*h/L.":[326],"average":[328],"(mean":[332],"\u00b1":[333,337],"SD)":[334],"115.7":[336],"34.0":[338],"mg*h/L,":[339],"so":[340],"value":[342],"chosen":[344],"as":[345,367,383],"target":[347,442,578],"model-based":[354,456],"approach.":[355],"Of":[356],"tested":[358],"covariates,":[359],"body":[360],"weight":[361],"cystatin":[363],"C":[364],"identified":[366,382],"significant":[368],"predictors":[369,384],"clearance,":[372],"neither":[374],"creatinine":[376,379],"nor":[377],"estimated":[378],"clearance":[380],"clearance.":[387],"indicated":[390],"three":[392,474],"collected":[395,479],"15-20":[397],"minutes,":[398,400],"50-60":[399],"3":[402,481,545,550],"hours":[403,482,551],"after":[404,535],"oral":[405,538],"administration":[406],"would":[407,441],"accurately":[408],"systemic":[410],"exposure.":[412],"Figure":[413],"demonstrates":[415],"example":[417],"patient,":[420],"demonstrating":[421],"profile":[424],"obtained":[425],"sparse":[428],"technique":[430],"(Panel":[431,448],"A)":[432],"predict":[437,461],"115":[446],"mg*h/L":[447],"B).":[449],"Conclusions:":[450],"We":[451],"have":[452],"established":[453],"Our":[468],"selective":[469],"only":[473,544],"be":[478],"over":[480,505,549],"therefore":[485],"more":[486,611],"feasible":[487],"practical,":[489],"very":[492],"children,":[494],"than":[495],"blood":[503,547],"collections":[504],"6-8":[506],"hours.":[507],"This":[508,580],"novel":[509],"approach":[511],"being":[513],"prospectively":[514],"evaluated":[515],"Therapeutic":[518],"Response":[519],"Evaluation":[520],"Adherence":[522],"Trial":[523],"(TREAT,":[524],"ClinicalTrials.gov":[525],"NCT02286154).":[526],"TREAT,":[528],"measured":[532],"HPLC":[534],"single":[537],"20":[541],"mg/kg,":[542],"requiring":[543],"fingerstick":[546],"accurate":[553],"assessment":[554],"each":[556],"patient's":[557],"unique":[558],"profile.":[561],"predicted":[563],"then":[566],"calculated":[567],"based":[568],"amount":[571],"drug":[573],"meet":[576],"AUC.":[579],"has":[582],"potential":[584],"individualize":[586],"optimize":[589],"titration":[592],"SCA,":[599],"such":[600],"achieved":[610],"quickly.":[612],"Disclosures":[613],"Off":[614],"Label":[615],"Use:":[616],"not":[619],"FDA-approved":[620],"anemia.":[626],"Ware:Bristol":[627],"Myers":[628],"Squibb:":[629],"Research":[630,633],"Funding;":[631,634],"Biomedomics:":[632],"Eli":[635],"Lilly:":[636],"Other:":[637],"DSMB":[638],"membership;":[639],"Bayer":[640],"Pharmaceuticals:":[641],"Consultancy.":[642]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-28T00:00:00"}